NASDAQ:APDN - Applied DNA Sciences Stock Price, Forecast & News

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Applied DNA Sciences Inc (NASDAQ:APDN) released its quarterly earnings results on Thursday, December, 12th. The technology company reported ($2.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.26) by $1.37. The technology company had revenue of $1.70 million for the quarter. View Applied DNA Sciences' Earnings History.

Applied DNA Sciences is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Applied DNA Sciences.

1 Wall Street analysts have issued 12 month price targets for Applied DNA Sciences' stock. Their forecasts range from $8.00 to $8.00. On average, they anticipate Applied DNA Sciences' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 107.3% from the stock's current price. View Analyst Price Targets for Applied DNA Sciences.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Applied DNA Sciences.

Media stories about APDN stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Applied DNA Sciences earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Applied DNA Sciences.

Applied DNA Sciences saw a decrease in short interest in January. As of January 15th, there was short interest totalling 100,800 shares, a decrease of 53.2% from the December 31st total of 215,400 shares. Based on an average daily volume of 524,100 shares, the days-to-cover ratio is currently 0.2 days. Currently, 2.9% of the company's shares are sold short. View Applied DNA Sciences' Current Options Chain.

Some companies that are related to Applied DNA Sciences include TENCENT HOLDING/ADR (TCEHY), Johnson Controls International (JCI), SEA (SE), Slack (WORK), BALFOUR BEATTY/S (BAFYY), NV5 Global (NVEE), Donnelley Financial Solutions (DFIN), Altisource Portfolio Solutions (ASPS), Performant Financial (PFMT), Helios and Matheson Analytics (HMNY), Ascent Capital Group Inc Series A (ASCMA) and Cornerworld (CWRL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Ekso Bionics (EKSO), TerraForm Global (GLBL), Anavex Life Sciences (AVXL), Inovio Pharmaceuticals (INO), Cominar REIT (CUF.UN), Catalyst Pharmaceuticals (CPRX), Adamis Pharmaceuticals (ADMP), Advanced Micro Devices (AMD), AVEO Pharmaceuticals (AVEO) and Opko Health (OPK).

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of APDN stock can currently be purchased for approximately $3.86.

Applied DNA Sciences has a market capitalization of $13.45 million and generates $5.39 million in revenue each year. Applied DNA Sciences employs 59 workers across the globe.View Additional Information About Applied DNA Sciences.

The official website for Applied DNA Sciences is http://www.adnas.com/.

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]